More than 14 years’ progress free survival of neratinib monotherapy for human epidermal growth factor receptor 2 (HER2) positive advanced breast cancer: a case report
Authors:
- Shaohua ZhangSZShaohua Zhang
- Feng LiFLFeng Li
Open Access
- 1 October 2021
- journal article
- research article
- Published by AME Publishing Company in Translational Breast Cancer Research
- Vol. 2, 32